Skip to content

Nicotine Reinforcement and Smoking-Cue Reactivity: Association With Genetic Polymorphisms

Nicotine Reinforcement and Smoking-Cue Reactivity: Association With Genetic Polymorphisms

Status
Completed
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT02921282
Enrollment
26
Registered
2016-10-03
Start date
2016-08-31
Completion date
2019-11-29
Last updated
2024-03-08

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Cigarette Smoking Behavior

Keywords

genes, cues, reward, smoking

Brief summary

In this study, potential associations between several genetic polymorphisms and nicotine dependence will be examined. The relative reinforcing efficacy of cigarettes using the forced-choice procedure will be assessed. In addition, reactivity to smoking cues using a reliable procedure will be conducted.

Detailed description

It is known that cannabinoid and dopamine receptors can be important modulators of response to nicotine and its associated cues. In this study participants will be genotyped to determine whether there is a relationship between CB1 or D3 genes and the reinforcing properties of nicotine or the subjective effects of nicotine-associated cues. In one session, participants will chose between two different cigarettes, each with different properties. In another session, physiological responses and craving will be measured when presented with cues that remind participants of nicotine. At some point during the study, blood will be collected for genotyping and this will processed to study whether CB1 or D3 genotype influences these responses to nicotine or cues.

Interventions

GENETICGenotype dopamine

Laboratory investigations of nicotine reinforcement

GENETICGenotype cannabinoids

Laboratory investigations of nicotine reinforcement

Sponsors

Centre for Addiction and Mental Health
Lead SponsorOTHER

Study design

Observational model
OTHER
Time perspective
PROSPECTIVE

Eligibility

Sex/Gender
ALL
Age
19 Years to 64 Years
Healthy volunteers
Yes

Inclusion criteria

1. 19-64 year old males and females 2. smoking at least 10 cigarettes per day for at least 1 year 3. positive urinary cotinine 4. medically and psychologically healthy as determined by screening criteria

Exclusion criteria

1. definite plan to reduce or quit tobacco use during the course of the study 2. treatment for tobacco dependence in the past 3 months 3. use of nicotine replacement products, bupropion, or varenicline in the past 3 months 4. consumption of more than 15 alcoholic drinks per week during the past month 5. use of any illicit drug more than twice per week during the past month 6. current use of any medication that would interfere with the protocol in the opinion of PI 7. under the influence of a drug or alcohol at any session 8. pregnant, nursing, or become pregnant during the study

Design outcomes

Primary

MeasureTime frameDescription
Number of puffs on a cigarette3 yearsPuffs taken from either a nicotinized or a denicotinized cigarette

Secondary

MeasureTime frameDescription
Craving in response to nicotine cues3 yearsCraving scores measured by questionnaires in response to either smoking-related or neutral cues
Physiological measures in response to cues3 yearsPhysiological measures (eg., heart rate and/or blood pressure) in response to smoking-related or neutral cues

Countries

Canada

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026